DAX23.667 +0,2%ESt505.465 -0,1%Top 10 Crypto15,62 +2,4%Dow46.121 -0,4%Nas22.498 -0,3%Bitcoin95.752 -0,8%Euro1,1752 +0,1%Öl69,08 ±0,0%Gold3.736 ±-0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 RENK RENK73 Gerresheimer A0LD6E Plug Power A1JA81 Alibaba A117ME D-Wave Quantum A3DSV9 Tesla A1CX3T Volkswagen (VW) vz. 766403 DroneShield A2DMAA Deutsche Telekom 555750 Amazon 906866 Novo Nordisk A3EU6F BYD A0M4W9 HENSOLDT HAG000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX schließt fester-- US-Börsen letzlich tiefer -- uniQure mit Kursexplosion dank Huntington-Therapie -- SoftBank und Oracle wollen KI-Infrastruktur ausbauen -- D-Wave, DroneShield, BYD im Fokus
Top News
Tesla-Aktie mit Rückenwind: Analyst lobt Elon Musk als "Kriegszeiten"-CEO im KI-Wettrüsten Tesla-Aktie mit Rückenwind: Analyst lobt Elon Musk als "Kriegszeiten"-CEO im KI-Wettrüsten
Skeptiker überzeugt: Weshalb DA Davidson bei der NVIDIA-Aktie umschwenkt Skeptiker überzeugt: Weshalb DA Davidson bei der NVIDIA-Aktie umschwenkt
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Edwards Lifesciences Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
63,59 EUR +0,34 EUR +0,54 %
BMN
74,67 USD +0,11 USD +0,15 %
BTT
Edwards Lifesciences jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.37,28 Mrd. EUR

KGV50,73Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN936853

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS28176E1082

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolEW

Edwards Lifesciences Aktien News

DatumMeistgelesen
BenzingaHere's How Much $100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth Today
BenzingaEdwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027
MotleyFoolEdwards Lifesciences (EW) Q2 2025 Earnings Call Transcript
Wer­bungEdwards Lifesciences-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
BenzingaEdwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance
BenzingaEdwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results
Benzinga6 Analysts Assess Edwards Lifesciences: What You Need To Know
ZacksCompared to Estimates, Edwards Lifesciences (EW) Q2 Earnings: A Look at Key Metrics
ZacksCurious about Edwards Lifesciences (EW) Q2 Performance? Explore Wall Street Estimates for Key Metrics
ZacksShould You Add Edwards Lifesciences Stock to Your Portfolio Now?
BenzingaWhat Analysts Are Saying About Edwards Lifesciences Stock
PR NewswireNYSE Content Advisory: Pre-Market update + Wall Street watches the Middle East
PR NewswireNYSE Content Advisory: Pre-Market update + Wall Street watches the Middle East
BenzingaAssessing Edwards Lifesciences: Insights From 6 Financial Analysts
ZacksShould Edwards Lifesciences Stock Remain in Your Portfolio Now?
BenzingaP/E Ratio Insights for Edwards Lifesciences
BenzingaEdwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens
BenzingaThis Edwards Lifesciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
ZacksEdwards Lifesciences (EW) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
ZacksUnlocking Q1 Potential of Edwards Lifesciences (EW): Exploring Wall Street Estimates for Key Metrics
BenzingaIs Edwards Lifesciences Gaining or Losing Market Support?
BenzingaEdwards Lifesciences Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
BenzingaA Look Into Edwards Lifesciences Inc's Price Over Earnings
ZacksShould Edwards Lifesciences Stock Remain in Your Portfolio Now?
BenzingaHeart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength
ZacksCompared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics
ZacksInsights Into Edwards Lifesciences (EW) Q4: Wall Street Projections for Key Metrics
BenzingaEdwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion
Benzinga11 Analysts Have This To Say About Edwards Lifesciences
ZacksEdwards Lifesciences Q4 Earnings Set to Benefit From TAVR Growth
ZacksAnalysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for
ZacksShould Edwards Lifesciences Stock Stay in Your Portfolio Now?
BusinesswireEdwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BenzingaAssessing Edwards Lifesciences: Insights From 20 Financial Analysts
ZacksIs it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?
PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
PR NewswireThe Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation(EW) Shareholders
BenzingaEdwards Lifesciences Outlines Vision For Growth At Investor Conference
BusinesswireEdwards Lifesciences Outlines Growth Strategy at Annual Investor Conference

Edwards Lifesciences News

Edwards Lifesciences News: auf dieser Seite finden Sie alle Edwards Lifesciences News und Nachrichten zur Edwards Lifesciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Edwards Lifesciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Edwards Lifesciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.